Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.81158736 |
2 | locomotory exploration behavior (GO:0035641) | 5.53685077 |
3 | synaptic vesicle maturation (GO:0016188) | 5.44451060 |
4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.25247666 |
5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.98087642 |
6 | vocalization behavior (GO:0071625) | 4.73905418 |
7 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.67310976 |
8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.64952068 |
9 | synaptic vesicle exocytosis (GO:0016079) | 4.58052986 |
10 | glutamate secretion (GO:0014047) | 4.52177147 |
11 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.49981478 |
12 | cerebellar granule cell differentiation (GO:0021707) | 4.43139149 |
13 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.42868909 |
14 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 4.28890150 |
15 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.21218757 |
16 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.16134666 |
17 | amino acid import (GO:0043090) | 4.07316582 |
18 | exploration behavior (GO:0035640) | 4.01796500 |
19 | sodium ion export (GO:0071436) | 4.01052704 |
20 | regulation of synaptic vesicle transport (GO:1902803) | 4.00384651 |
21 | neurotransmitter secretion (GO:0007269) | 3.99017681 |
22 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.95734614 |
23 | cellular potassium ion homeostasis (GO:0030007) | 3.94139888 |
24 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.93000445 |
25 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.89467494 |
26 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.84363596 |
27 | protein localization to synapse (GO:0035418) | 3.82633381 |
28 | regulation of synapse structural plasticity (GO:0051823) | 3.82603122 |
29 | gamma-aminobutyric acid transport (GO:0015812) | 3.82597231 |
30 | proline transport (GO:0015824) | 3.80997184 |
31 | layer formation in cerebral cortex (GO:0021819) | 3.74073618 |
32 | synaptic transmission, glutamatergic (GO:0035249) | 3.70497901 |
33 | neuronal action potential propagation (GO:0019227) | 3.68522135 |
34 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.62351660 |
35 | glutamate receptor signaling pathway (GO:0007215) | 3.60860434 |
36 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.59842377 |
37 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.59495793 |
38 | activation of protein kinase A activity (GO:0034199) | 3.58422207 |
39 | long-term memory (GO:0007616) | 3.56979533 |
40 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.56929368 |
41 | regulation of ARF protein signal transduction (GO:0032012) | 3.51807655 |
42 | positive regulation of Rap GTPase activity (GO:0032854) | 3.50372212 |
43 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.47057074 |
44 | neuron-neuron synaptic transmission (GO:0007270) | 3.44526658 |
45 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.42624779 |
46 | dendritic spine morphogenesis (GO:0060997) | 3.40980751 |
47 | positive regulation of membrane potential (GO:0045838) | 3.40186393 |
48 | neuron cell-cell adhesion (GO:0007158) | 3.35361270 |
49 | cell communication by electrical coupling (GO:0010644) | 3.31944715 |
50 | regulation of postsynaptic membrane potential (GO:0060078) | 3.30016622 |
51 | synaptic vesicle endocytosis (GO:0048488) | 3.29607623 |
52 | neuromuscular process controlling balance (GO:0050885) | 3.28103880 |
53 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.25144253 |
54 | regulation of synaptic plasticity (GO:0048167) | 3.21145095 |
55 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.19085291 |
56 | neurotransmitter transport (GO:0006836) | 3.17865245 |
57 | regulation of synapse maturation (GO:0090128) | 3.14969902 |
58 | glycine transport (GO:0015816) | 3.14133225 |
59 | membrane depolarization during action potential (GO:0086010) | 3.13796734 |
60 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.11647281 |
61 | regulation of Rap GTPase activity (GO:0032317) | 3.10508758 |
62 | long-term synaptic potentiation (GO:0060291) | 3.10467398 |
63 | dendrite morphogenesis (GO:0048813) | 3.10338297 |
64 | vesicle transport along microtubule (GO:0047496) | 3.09291955 |
65 | regulation of ARF GTPase activity (GO:0032312) | 3.09034003 |
66 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.08340919 |
67 | positive regulation of synapse maturation (GO:0090129) | 3.08219117 |
68 | L-amino acid import (GO:0043092) | 3.06483814 |
69 | neuromuscular process controlling posture (GO:0050884) | 3.05344460 |
70 | signal complex assembly (GO:0007172) | 3.05177367 |
71 | regulation of neurotransmitter secretion (GO:0046928) | 3.03542357 |
72 | prepulse inhibition (GO:0060134) | 3.03146846 |
73 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.01149087 |
74 | mannose metabolic process (GO:0006013) | 2.98526978 |
75 | regulation of early endosome to late endosome transport (GO:2000641) | 2.96170820 |
76 | potassium ion import (GO:0010107) | 2.93848612 |
77 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.92341375 |
78 | establishment of nucleus localization (GO:0040023) | 2.90476573 |
79 | nerve growth factor signaling pathway (GO:0038180) | 2.89829989 |
80 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.89764333 |
81 | regulation of neurotransmitter levels (GO:0001505) | 2.89210039 |
82 | chemosensory behavior (GO:0007635) | 2.89095314 |
83 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.88881303 |
84 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.88696187 |
85 | membrane depolarization (GO:0051899) | 2.88104806 |
86 | membrane hyperpolarization (GO:0060081) | 2.87822855 |
87 | response to auditory stimulus (GO:0010996) | 2.86785022 |
88 | transmission of nerve impulse (GO:0019226) | 2.84445013 |
89 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.83259468 |
90 | cellular sodium ion homeostasis (GO:0006883) | 2.82427612 |
91 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.80223710 |
92 | neuron recognition (GO:0008038) | 2.79931034 |
93 | positive regulation of protein dephosphorylation (GO:0035307) | 2.78596483 |
94 | regulation of neurotransmitter transport (GO:0051588) | 2.77551416 |
95 | cell differentiation in hindbrain (GO:0021533) | 2.75444869 |
96 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.74768395 |
97 | positive regulation of synaptic transmission (GO:0050806) | 2.72441389 |
98 | positive regulation of dendritic spine development (GO:0060999) | 2.70625768 |
99 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.70600826 |
100 | striatum development (GO:0021756) | 2.70460540 |
101 | auditory behavior (GO:0031223) | 2.70383952 |
102 | alanine transport (GO:0032328) | 2.69948517 |
103 | regulation of vesicle fusion (GO:0031338) | 2.69355453 |
104 | neuromuscular process (GO:0050905) | 2.68972782 |
105 | innervation (GO:0060384) | 2.68786906 |
106 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.68012501 |
107 | positive regulation of neurotransmitter transport (GO:0051590) | 2.67041251 |
108 | neuronal ion channel clustering (GO:0045161) | 2.66966463 |
109 | potassium ion homeostasis (GO:0055075) | 2.66916266 |
110 | axonal fasciculation (GO:0007413) | 2.66549286 |
111 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.66071997 |
112 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.65893049 |
113 | social behavior (GO:0035176) | 2.65145516 |
114 | intraspecies interaction between organisms (GO:0051703) | 2.65145516 |
115 | mating behavior (GO:0007617) | 2.64916090 |
116 | response to histamine (GO:0034776) | 2.63682830 |
117 | presynaptic membrane assembly (GO:0097105) | 2.63220251 |
118 | organelle transport along microtubule (GO:0072384) | 2.62906727 |
119 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.62858969 |
120 | regulation of dendritic spine development (GO:0060998) | 2.62802335 |
121 | peptidyl-threonine phosphorylation (GO:0018107) | 2.54877517 |
122 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.53612835 |
123 | cerebellar Purkinje cell layer development (GO:0021680) | 2.52582287 |
124 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.51099827 |
125 | cell migration in hindbrain (GO:0021535) | 2.51030223 |
126 | cellular response to monoamine stimulus (GO:0071868) | 2.48108760 |
127 | cellular response to catecholamine stimulus (GO:0071870) | 2.48108760 |
128 | regulation of beta-amyloid formation (GO:1902003) | 2.46777175 |
129 | dopamine receptor signaling pathway (GO:0007212) | 2.46745102 |
130 | vesicle docking involved in exocytosis (GO:0006904) | 2.46650695 |
131 | visual learning (GO:0008542) | 2.46024333 |
132 | regulation of histone H3-K27 methylation (GO:0061085) | 2.44980267 |
133 | regulation of exocytosis (GO:0017157) | 2.44530045 |
134 | protein localization to endosome (GO:0036010) | 2.39721207 |
135 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.39426454 |
136 | axon ensheathment in central nervous system (GO:0032291) | 2.39240504 |
137 | central nervous system myelination (GO:0022010) | 2.39240504 |
138 | positive regulation of fibroblast migration (GO:0010763) | 2.39180117 |
139 | regulation of synaptic transmission (GO:0050804) | 2.38986304 |
140 | dendritic spine organization (GO:0097061) | 2.36656688 |
141 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.36281474 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.50993521 |
2 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.45840831 |
3 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.97234713 |
4 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.81567113 |
5 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.68351116 |
6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.60147377 |
7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.58327475 |
8 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.57179850 |
9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.42454563 |
10 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.40885034 |
11 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.38987718 |
12 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.35858270 |
13 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.33653918 |
14 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.28043921 |
15 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.25337389 |
16 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.25337389 |
17 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.24664845 |
18 | MYC_22102868_ChIP-Seq_BL_Human | 2.23182358 |
19 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.21413798 |
20 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.19473533 |
21 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.19393897 |
22 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.18280929 |
23 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.17855158 |
24 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.17369048 |
25 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.09457737 |
26 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.05862168 |
27 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.97989103 |
28 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.94399649 |
29 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.93935963 |
30 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.86489676 |
31 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.86308516 |
32 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.85846526 |
33 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.84772218 |
34 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.82302520 |
35 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.79338042 |
36 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.71861052 |
37 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.69830108 |
38 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.69598702 |
39 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.67915086 |
40 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.67661313 |
41 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.62922814 |
42 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.58486602 |
43 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.56603484 |
44 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.55405838 |
45 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.54280745 |
46 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.53520543 |
47 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.53427170 |
48 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.52175952 |
49 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.48675487 |
50 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.46391564 |
51 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.45075413 |
52 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.41255615 |
53 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.41237988 |
54 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.39490965 |
55 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.39213202 |
56 | KDM2B_26808549_Chip-Seq_K562_Human | 1.39108033 |
57 | SPI1_23127762_ChIP-Seq_K562_Human | 1.38391113 |
58 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.37778634 |
59 | GATA1_19941826_ChIP-Seq_K562_Human | 1.37325946 |
60 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.37242253 |
61 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.36333356 |
62 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.35813466 |
63 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.35420485 |
64 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.35208734 |
65 | AR_19668381_ChIP-Seq_PC3_Human | 1.33221157 |
66 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.32776108 |
67 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.31442692 |
68 | P68_20966046_ChIP-Seq_HELA_Human | 1.30849752 |
69 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.30311723 |
70 | STAT3_23295773_ChIP-Seq_U87_Human | 1.28249226 |
71 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.27811742 |
72 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.26873692 |
73 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.26792990 |
74 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.26506755 |
75 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.26306473 |
76 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.25858541 |
77 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.25621263 |
78 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.24310119 |
79 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.23325232 |
80 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.22624347 |
81 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.22290342 |
82 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.21806952 |
83 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21266853 |
84 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21198724 |
85 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.21097026 |
86 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.20787758 |
87 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.19667011 |
88 | MAF_26560356_Chip-Seq_TH1_Human | 1.17546631 |
89 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.16835194 |
90 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.16672801 |
91 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.15621133 |
92 | TCF4_23295773_ChIP-Seq_U87_Human | 1.15030370 |
93 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.12806077 |
94 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.12173131 |
95 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.12017192 |
96 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.11654451 |
97 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.11445895 |
98 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.11310325 |
99 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.10401639 |
100 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.09785307 |
101 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.08218787 |
102 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.08194604 |
103 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07838033 |
104 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.07787159 |
105 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.07613787 |
106 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.06951696 |
107 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.06873156 |
108 | RXR_22108803_ChIP-Seq_LS180_Human | 1.05914118 |
109 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.05373249 |
110 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05217255 |
111 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.04920040 |
112 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.04754593 |
113 | TP53_16413492_ChIP-PET_HCT116_Human | 1.04749747 |
114 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.04175840 |
115 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03738215 |
116 | MAF_26560356_Chip-Seq_TH2_Human | 1.03203500 |
117 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.03020851 |
118 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.02779548 |
119 | UTX_26944678_Chip-Seq_JUKART_Human | 1.02738413 |
120 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.02650949 |
121 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.02555187 |
122 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.02089108 |
123 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.01457113 |
124 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.01333348 |
125 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.01090525 |
126 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.00947709 |
127 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.99231992 |
128 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.98620587 |
129 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.98534192 |
130 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.97930934 |
131 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.97852356 |
132 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.96897029 |
133 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.96854608 |
134 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.96712578 |
135 | P300_19829295_ChIP-Seq_ESCs_Human | 0.96450795 |
136 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.96118577 |
137 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.95327456 |
138 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.95236891 |
139 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.93901796 |
140 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.93863707 |
141 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.93687497 |
142 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.92209349 |
143 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.91602520 |
144 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.90440869 |
145 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.89881879 |
146 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.89396313 |
147 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.88633263 |
148 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88266574 |
149 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.88266574 |
150 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.87966388 |
151 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.86308352 |
152 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.84363842 |
153 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.83953972 |
154 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.83787478 |
155 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.82980009 |
156 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.82105525 |
157 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.81886534 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 6.74448832 |
2 | MP0003635_abnormal_synaptic_transmissio | 4.07503624 |
3 | MP0003880_abnormal_central_pattern | 3.83810688 |
4 | MP0004270_analgesia | 3.51580565 |
5 | MP0009745_abnormal_behavioral_response | 3.28491434 |
6 | MP0002063_abnormal_learning/memory/cond | 3.26170299 |
7 | MP0002064_seizures | 3.11566440 |
8 | MP0009046_muscle_twitch | 3.08161702 |
9 | MP0005423_abnormal_somatic_nervous | 2.88755853 |
10 | MP0002822_catalepsy | 2.88050200 |
11 | MP0009780_abnormal_chondrocyte_physiolo | 2.66326658 |
12 | MP0002572_abnormal_emotion/affect_behav | 2.64975037 |
13 | MP0001968_abnormal_touch/_nociception | 2.57873513 |
14 | MP0002272_abnormal_nervous_system | 2.41111569 |
15 | MP0002909_abnormal_adrenal_gland | 2.38571468 |
16 | MP0001486_abnormal_startle_reflex | 2.37427093 |
17 | MP0001501_abnormal_sleep_pattern | 2.36452886 |
18 | MP0000569_abnormal_digit_pigmentation | 2.35021458 |
19 | MP0002734_abnormal_mechanical_nocicepti | 2.26158368 |
20 | MP0003705_abnormal_hypodermis_morpholog | 2.18815789 |
21 | MP0008569_lethality_at_weaning | 2.12056567 |
22 | MP0004858_abnormal_nervous_system | 2.10669129 |
23 | MP0001348_abnormal_lacrimal_gland | 1.98805782 |
24 | MP0002736_abnormal_nociception_after | 1.93647156 |
25 | MP0003787_abnormal_imprinting | 1.89829149 |
26 | MP0001440_abnormal_grooming_behavior | 1.89516378 |
27 | MP0002067_abnormal_sensory_capabilities | 1.87831280 |
28 | MP0008961_abnormal_basal_metabolism | 1.87084623 |
29 | MP0005058_abnormal_lysosome_morphology | 1.81156679 |
30 | MP0005646_abnormal_pituitary_gland | 1.78649814 |
31 | MP0004811_abnormal_neuron_physiology | 1.76487041 |
32 | MP0002735_abnormal_chemical_nociception | 1.76038248 |
33 | MP0003329_amyloid_beta_deposits | 1.70652203 |
34 | MP0002733_abnormal_thermal_nociception | 1.67654602 |
35 | MP0004924_abnormal_behavior | 1.66242939 |
36 | MP0005386_behavior/neurological_phenoty | 1.66242939 |
37 | MP0001970_abnormal_pain_threshold | 1.63702620 |
38 | MP0002557_abnormal_social/conspecific_i | 1.62316471 |
39 | MP0003123_paternal_imprinting | 1.58617124 |
40 | MP0004885_abnormal_endolymph | 1.52530641 |
41 | MP0003633_abnormal_nervous_system | 1.52426936 |
42 | MP0002184_abnormal_innervation | 1.46438664 |
43 | MP0008260_abnormal_autophagy | 1.45613580 |
44 | MP0003879_abnormal_hair_cell | 1.44745820 |
45 | MP0003283_abnormal_digestive_organ | 1.43989213 |
46 | MP0005451_abnormal_body_composition | 1.43332777 |
47 | MP0000778_abnormal_nervous_system | 1.39812007 |
48 | MP0000955_abnormal_spinal_cord | 1.37954418 |
49 | MP0009278_abnormal_bone_marrow | 1.37746147 |
50 | MP0002066_abnormal_motor_capabilities/c | 1.33294978 |
51 | MP0005645_abnormal_hypothalamus_physiol | 1.30854478 |
52 | MP0001984_abnormal_olfaction | 1.29784307 |
53 | MP0003690_abnormal_glial_cell | 1.27691993 |
54 | MP0002882_abnormal_neuron_morphology | 1.27120551 |
55 | MP0005076_abnormal_cell_differentiation | 1.24051341 |
56 | MP0001502_abnormal_circadian_rhythm | 1.22353791 |
57 | MP0004043_abnormal_pH_regulation | 1.22276776 |
58 | MP0003631_nervous_system_phenotype | 1.20828580 |
59 | MP0000751_myopathy | 1.17791855 |
60 | MP0010234_abnormal_vibrissa_follicle | 1.17419600 |
61 | MP0004510_myositis | 1.16881207 |
62 | MP0003172_abnormal_lysosome_physiology | 1.15023514 |
63 | MP0003045_fibrosis | 1.13686932 |
64 | MP0003091_abnormal_cell_migration | 1.08265162 |
65 | MP0001177_atelectasis | 1.04450147 |
66 | MP0003436_decreased_susceptibility_to | 1.02473056 |
67 | MP0002152_abnormal_brain_morphology | 1.02092878 |
68 | MP0003122_maternal_imprinting | 1.01562960 |
69 | MP0003075_altered_response_to | 1.00169380 |
70 | MP0000013_abnormal_adipose_tissue | 1.00169156 |
71 | MP0005535_abnormal_body_temperature | 0.98590631 |
72 | MP0002069_abnormal_eating/drinking_beha | 0.98371010 |
73 | MP0002229_neurodegeneration | 0.98136722 |
74 | MP0004947_skin_inflammation | 0.96116488 |
75 | MP0008874_decreased_physiological_sensi | 0.92899150 |
76 | MP0004085_abnormal_heartbeat | 0.91439463 |
77 | MP0000604_amyloidosis | 0.88573202 |
78 | MP0001849_ear_inflammation | 0.88469143 |
79 | MP0005551_abnormal_eye_electrophysiolog | 0.88312513 |
80 | MP0003634_abnormal_glial_cell | 0.86605684 |
81 | MP0004185_abnormal_adipocyte_glucose | 0.86145029 |
82 | MP0010386_abnormal_urinary_bladder | 0.85812432 |
83 | MP0004142_abnormal_muscle_tone | 0.84521935 |
84 | MP0003632_abnormal_nervous_system | 0.83662619 |
85 | MP0004130_abnormal_muscle_cell | 0.83546955 |
86 | MP0008872_abnormal_physiological_respon | 0.82746064 |
87 | MP0006276_abnormal_autonomic_nervous | 0.81552138 |
88 | MP0003763_abnormal_thymus_physiology | 0.81262315 |
89 | MP0005167_abnormal_blood-brain_barrier | 0.81202760 |
90 | MP0003183_abnormal_peptide_metabolism | 0.80873084 |
91 | MP0002009_preneoplasia | 0.80501413 |
92 | MP0004145_abnormal_muscle_electrophysio | 0.80439991 |
93 | MP0004233_abnormal_muscle_weight | 0.80365175 |
94 | MP0002090_abnormal_vision | 0.80061803 |
95 | MP0003191_abnormal_cellular_cholesterol | 0.79098064 |
96 | MP0005666_abnormal_adipose_tissue | 0.76094589 |
97 | MP0000681_abnormal_thyroid_gland | 0.75415869 |
98 | MP0003303_peritoneal_inflammation | 0.75395436 |
99 | MP0002249_abnormal_larynx_morphology | 0.75084470 |
100 | MP0002837_dystrophic_cardiac_calcinosis | 0.74914727 |
101 | MP0001765_abnormal_ion_homeostasis | 0.72802645 |
102 | MP0005621_abnormal_cell_physiology | 0.69477198 |
103 | MP0004484_altered_response_of | 0.68642275 |
104 | MP0005166_decreased_susceptibility_to | 0.67872444 |
105 | MP0003300_gastrointestinal_ulcer | 0.67848465 |
106 | MP0000678_abnormal_parathyroid_gland | 0.66917515 |
107 | MP0000920_abnormal_myelination | 0.66711693 |
108 | MP0004215_abnormal_myocardial_fiber | 0.65268438 |
109 | MP0001299_abnormal_eye_distance/ | 0.64975255 |
110 | MP0001851_eye_inflammation | 0.64687508 |
111 | MP0005623_abnormal_meninges_morphology | 0.63489145 |
112 | MP0000003_abnormal_adipose_tissue | 0.63188922 |
113 | MP0004742_abnormal_vestibular_system | 0.62755396 |
114 | MP0009840_abnormal_foam_cell | 0.62726605 |
115 | MP0001529_abnormal_vocalization | 0.62160068 |
116 | MP0005310_abnormal_salivary_gland | 0.59640617 |
117 | MP0000747_muscle_weakness | 0.58756834 |
118 | MP0005409_darkened_coat_color | 0.58518812 |
119 | MP0002089_abnormal_postnatal_growth/wei | 0.57987776 |
120 | MP0003566_abnormal_cell_adhesion | 0.57456304 |
121 | MP0002998_abnormal_bone_remodeling | 0.57447504 |
122 | MP0002396_abnormal_hematopoietic_system | 0.57440669 |
123 | MP0001545_abnormal_hematopoietic_system | 0.57280733 |
124 | MP0005397_hematopoietic_system_phenotyp | 0.57280733 |
125 | MP0003137_abnormal_impulse_conducting | 0.56599655 |
126 | MP0005464_abnormal_platelet_physiology | 0.55883440 |
127 | MP0000631_abnormal_neuroendocrine_gland | 0.55528630 |
128 | MP0005375_adipose_tissue_phenotype | 0.55413628 |
129 | MP0002877_abnormal_melanocyte_morpholog | 0.54874651 |
130 | MP0001943_abnormal_respiration | 0.53816760 |
131 | MP0010769_abnormal_survival | 0.53798789 |
132 | MP0001963_abnormal_hearing_physiology | 0.51519894 |
133 | MP0001905_abnormal_dopamine_level | 0.51134681 |
134 | MP0010770_preweaning_lethality | 0.49793929 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 6.36847514 |
2 | Myokymia (HP:0002411) | 5.56162469 |
3 | Focal seizures (HP:0007359) | 5.16329322 |
4 | Visual hallucinations (HP:0002367) | 4.47488590 |
5 | Action tremor (HP:0002345) | 4.02685804 |
6 | Epileptic encephalopathy (HP:0200134) | 4.00338006 |
7 | Febrile seizures (HP:0002373) | 3.83933883 |
8 | Progressive cerebellar ataxia (HP:0002073) | 3.61684130 |
9 | Atonic seizures (HP:0010819) | 3.58956402 |
10 | Absence seizures (HP:0002121) | 3.37888397 |
11 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.30665732 |
12 | Supranuclear gaze palsy (HP:0000605) | 3.28702076 |
13 | Generalized tonic-clonic seizures (HP:0002069) | 3.23617368 |
14 | Postural instability (HP:0002172) | 3.21085204 |
15 | Dysmetric saccades (HP:0000641) | 3.20396933 |
16 | Dialeptic seizures (HP:0011146) | 3.18134164 |
17 | Gaze-evoked nystagmus (HP:0000640) | 3.16997235 |
18 | Abnormality of the lower motor neuron (HP:0002366) | 3.13415080 |
19 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.12136627 |
20 | Dysdiadochokinesis (HP:0002075) | 3.11639635 |
21 | Ankle clonus (HP:0011448) | 3.08764826 |
22 | Poor eye contact (HP:0000817) | 3.08481893 |
23 | Depression (HP:0000716) | 3.06531249 |
24 | Impaired social interactions (HP:0000735) | 3.03501978 |
25 | Abnormal social behavior (HP:0012433) | 3.03501978 |
26 | Impaired smooth pursuit (HP:0007772) | 3.01491433 |
27 | Genetic anticipation (HP:0003743) | 2.90491199 |
28 | Broad-based gait (HP:0002136) | 2.84816383 |
29 | Papilledema (HP:0001085) | 2.82621487 |
30 | Truncal ataxia (HP:0002078) | 2.82499442 |
31 | Dysmetria (HP:0001310) | 2.77796980 |
32 | Hemiplegia (HP:0002301) | 2.76232677 |
33 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.71989779 |
34 | Peripheral hypomyelination (HP:0007182) | 2.71360721 |
35 | Urinary urgency (HP:0000012) | 2.69058906 |
36 | Abnormal eating behavior (HP:0100738) | 2.67151224 |
37 | Cerebral aneurysm (HP:0004944) | 2.58907124 |
38 | Slow saccadic eye movements (HP:0000514) | 2.54593292 |
39 | Macroorchidism (HP:0000053) | 2.51838865 |
40 | Intention tremor (HP:0002080) | 2.51130139 |
41 | Tetraplegia (HP:0002445) | 2.50468833 |
42 | Bowel incontinence (HP:0002607) | 2.45371698 |
43 | Bradykinesia (HP:0002067) | 2.40976101 |
44 | Anxiety (HP:0000739) | 2.40767605 |
45 | Resting tremor (HP:0002322) | 2.39062121 |
46 | Drooling (HP:0002307) | 2.38283205 |
47 | Excessive salivation (HP:0003781) | 2.38283205 |
48 | Hyperventilation (HP:0002883) | 2.36467496 |
49 | Amblyopia (HP:0000646) | 2.36045300 |
50 | Insidious onset (HP:0003587) | 2.35836404 |
51 | Termporal pattern (HP:0011008) | 2.35836404 |
52 | Spastic gait (HP:0002064) | 2.33054429 |
53 | Ventricular fibrillation (HP:0001663) | 2.32707196 |
54 | Truncus arteriosus (HP:0001660) | 2.32181677 |
55 | Abnormality of the fingertips (HP:0001211) | 2.29806938 |
56 | Scanning speech (HP:0002168) | 2.29757346 |
57 | Bundle branch block (HP:0011710) | 2.29618404 |
58 | Stereotypic behavior (HP:0000733) | 2.26479881 |
59 | Abnormal large intestine physiology (HP:0012700) | 2.26005460 |
60 | Status epilepticus (HP:0002133) | 2.25963277 |
61 | Hemiparesis (HP:0001269) | 2.25517938 |
62 | Apathy (HP:0000741) | 2.25283482 |
63 | Abnormality of binocular vision (HP:0011514) | 2.24407635 |
64 | Diplopia (HP:0000651) | 2.24407635 |
65 | Pointed chin (HP:0000307) | 2.23531611 |
66 | Impaired vibratory sensation (HP:0002495) | 2.23508737 |
67 | Hyperthyroidism (HP:0000836) | 2.21000597 |
68 | Torticollis (HP:0000473) | 2.19439745 |
69 | Insomnia (HP:0100785) | 2.18941345 |
70 | Neuronal loss in central nervous system (HP:0002529) | 2.18824404 |
71 | Hand muscle atrophy (HP:0009130) | 2.16178511 |
72 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.14826976 |
73 | Annular pancreas (HP:0001734) | 2.14780945 |
74 | Lower limb muscle weakness (HP:0007340) | 2.09451139 |
75 | Epileptiform EEG discharges (HP:0011182) | 2.04342463 |
76 | Increased circulating renin level (HP:0000848) | 2.02534241 |
77 | Cerebral inclusion bodies (HP:0100314) | 2.01722363 |
78 | Diminished motivation (HP:0000745) | 2.01075693 |
79 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.00502041 |
80 | Lower limb amyotrophy (HP:0007210) | 1.99374005 |
81 | Akinesia (HP:0002304) | 1.98552061 |
82 | EEG with generalized epileptiform discharges (HP:0011198) | 1.98393815 |
83 | Absent speech (HP:0001344) | 1.98113164 |
84 | Mutism (HP:0002300) | 1.97343201 |
85 | Blue irides (HP:0000635) | 1.96705642 |
86 | Lower limb asymmetry (HP:0100559) | 1.96090719 |
87 | Ankyloglossia (HP:0010296) | 1.95330486 |
88 | Abnormality of saccadic eye movements (HP:0000570) | 1.94199613 |
89 | Hyperacusis (HP:0010780) | 1.93918756 |
90 | Focal dystonia (HP:0004373) | 1.91618847 |
91 | Broad face (HP:0000283) | 1.90267554 |
92 | Hypsarrhythmia (HP:0002521) | 1.90175392 |
93 | Ocular albinism (HP:0001107) | 1.89868311 |
94 | Spinal canal stenosis (HP:0003416) | 1.89567283 |
95 | Agitation (HP:0000713) | 1.87308156 |
96 | Decreased motor nerve conduction velocity (HP:0003431) | 1.84356382 |
97 | Gait ataxia (HP:0002066) | 1.83781921 |
98 | Progressive inability to walk (HP:0002505) | 1.83627653 |
99 | Onion bulb formation (HP:0003383) | 1.83374722 |
100 | Hypercortisolism (HP:0001578) | 1.83369657 |
101 | Megalencephaly (HP:0001355) | 1.83008373 |
102 | Neoplasm of the heart (HP:0100544) | 1.82492411 |
103 | Distal sensory impairment (HP:0002936) | 1.82066360 |
104 | Abnormal gallbladder physiology (HP:0012438) | 1.81732484 |
105 | Cholecystitis (HP:0001082) | 1.81732484 |
106 | Abnormality of the periventricular white matter (HP:0002518) | 1.81038185 |
107 | Abnormality of the corticospinal tract (HP:0002492) | 1.79874629 |
108 | Upper limb amyotrophy (HP:0009129) | 1.79625471 |
109 | Distal upper limb amyotrophy (HP:0007149) | 1.79625471 |
110 | Clonus (HP:0002169) | 1.78296303 |
111 | Hammertoe (HP:0001765) | 1.78178917 |
112 | Neurofibrillary tangles (HP:0002185) | 1.77715978 |
113 | Elfin facies (HP:0004428) | 1.77310515 |
114 | Distal lower limb amyotrophy (HP:0008944) | 1.76608375 |
115 | Cellulitis (HP:0100658) | 1.74775163 |
116 | Dysostosis multiplex (HP:0000943) | 1.72821112 |
117 | Rapidly progressive (HP:0003678) | 1.72487764 |
118 | Deep palmar crease (HP:0006191) | 1.71330453 |
119 | Aplasia involving bones of the extremities (HP:0009825) | 1.70813994 |
120 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.70813994 |
121 | Aplasia of the phalanges of the hand (HP:0009802) | 1.70813994 |
122 | Abnormal EKG (HP:0003115) | 1.70066588 |
123 | Rigidity (HP:0002063) | 1.69882095 |
124 | Obstructive sleep apnea (HP:0002870) | 1.69718845 |
125 | Personality changes (HP:0000751) | 1.68333254 |
126 | Craniofacial dystonia (HP:0012179) | 1.68249619 |
127 | Incomplete penetrance (HP:0003829) | 1.68085276 |
128 | Prolonged QT interval (HP:0001657) | 1.67652317 |
129 | Amyotrophic lateral sclerosis (HP:0007354) | 1.67536847 |
130 | Sleep apnea (HP:0010535) | 1.67205800 |
131 | Abnormality of oral frenula (HP:0000190) | 1.65694697 |
132 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.65275535 |
133 | Eczematoid dermatitis (HP:0000976) | 1.64640294 |
134 | Disproportionate tall stature (HP:0001519) | 1.64005244 |
135 | Cerebral hypomyelination (HP:0006808) | 1.62055334 |
136 | Germ cell neoplasia (HP:0100728) | 1.61964705 |
137 | Foot dorsiflexor weakness (HP:0009027) | 1.60262174 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NTRK3 | 4.56635146 |
2 | EPHA4 | 3.68568685 |
3 | MAP3K9 | 3.54984930 |
4 | PRKD3 | 2.70006964 |
5 | MAP3K4 | 2.62408391 |
6 | DAPK2 | 2.47549064 |
7 | PAK6 | 2.23880196 |
8 | MINK1 | 2.20381627 |
9 | KSR2 | 2.15719034 |
10 | CDK12 | 2.13637286 |
11 | CAMKK1 | 2.13218849 |
12 | RIPK4 | 2.01480879 |
13 | MARK1 | 1.93525360 |
14 | NTRK2 | 1.87123319 |
15 | EEF2K | 1.81912818 |
16 | STK38 | 1.76865879 |
17 | MAP2K7 | 1.68775780 |
18 | NTRK1 | 1.64681306 |
19 | MAP2K4 | 1.62492744 |
20 | SGK3 | 1.51925786 |
21 | SIK2 | 1.50421181 |
22 | MAP3K13 | 1.49846714 |
23 | PRKCH | 1.44835681 |
24 | KSR1 | 1.44557068 |
25 | CAMK1G | 1.43760820 |
26 | TYRO3 | 1.40392828 |
27 | MAP3K2 | 1.40335374 |
28 | CDK5 | 1.39543794 |
29 | SGK2 | 1.38918307 |
30 | DAPK1 | 1.33201491 |
31 | SMG1 | 1.30318851 |
32 | ERN1 | 1.29817186 |
33 | SGK223 | 1.29767939 |
34 | SGK494 | 1.29767939 |
35 | SIK1 | 1.28617777 |
36 | RIPK1 | 1.20198662 |
37 | FES | 1.18995830 |
38 | TNIK | 1.15707231 |
39 | BMPR2 | 1.10218456 |
40 | WNK1 | 1.08896047 |
41 | FGFR4 | 1.06988150 |
42 | TRIB3 | 1.06383647 |
43 | RET | 1.05912566 |
44 | TAOK1 | 1.04601683 |
45 | MAPK12 | 1.03481968 |
46 | PRPF4B | 1.02671562 |
47 | UHMK1 | 1.02226848 |
48 | MAP3K12 | 1.00376776 |
49 | STK11 | 0.98786097 |
50 | ALK | 0.98539377 |
51 | LMTK2 | 0.97785024 |
52 | CAMKK2 | 0.96522064 |
53 | PRKCG | 0.96368280 |
54 | PDK1 | 0.91879913 |
55 | CDC42BPA | 0.89261582 |
56 | PNCK | 0.87868382 |
57 | MAP3K7 | 0.87641079 |
58 | SGK1 | 0.87224591 |
59 | CDK19 | 0.86600514 |
60 | PINK1 | 0.86560734 |
61 | NEK6 | 0.86092733 |
62 | CAMK1 | 0.85814031 |
63 | MAPK13 | 0.83548891 |
64 | MARK2 | 0.83388954 |
65 | PDGFRA | 0.82693114 |
66 | CAMK1D | 0.82433963 |
67 | PTK2B | 0.77738551 |
68 | PDPK1 | 0.77013227 |
69 | GRK5 | 0.76617783 |
70 | MAP2K3 | 0.75648714 |
71 | SCYL2 | 0.75392805 |
72 | PLK2 | 0.75343452 |
73 | MAP3K1 | 0.73923664 |
74 | ICK | 0.73192465 |
75 | PHKG2 | 0.72852354 |
76 | PHKG1 | 0.72852354 |
77 | MAP4K1 | 0.72667754 |
78 | OXSR1 | 0.72147983 |
79 | BRAF | 0.71168051 |
80 | TNK2 | 0.69963615 |
81 | WNK4 | 0.68568591 |
82 | MTOR | 0.68139680 |
83 | JAK2 | 0.67767334 |
84 | DMPK | 0.65610842 |
85 | CAMK2A | 0.65254535 |
86 | MAP3K11 | 0.64377656 |
87 | PAK3 | 0.61579429 |
88 | RPS6KA3 | 0.60357167 |
89 | CDK15 | 0.58640779 |
90 | DYRK1A | 0.58554412 |
91 | RAF1 | 0.58469974 |
92 | CDK18 | 0.57622058 |
93 | CAMK4 | 0.57475753 |
94 | TYK2 | 0.57346310 |
95 | ZAP70 | 0.56794771 |
96 | WNK3 | 0.56237321 |
97 | IRAK2 | 0.55906425 |
98 | FGFR2 | 0.55843926 |
99 | RPS6KA2 | 0.53991308 |
100 | PRKD2 | 0.52486625 |
101 | MAPK11 | 0.52212678 |
102 | HIPK2 | 0.52177464 |
103 | BMX | 0.49782005 |
104 | CDK11A | 0.47466388 |
105 | CDK14 | 0.46944905 |
106 | MAPK10 | 0.46938555 |
107 | FYN | 0.46711291 |
108 | PDGFRB | 0.46536962 |
109 | CAMK2B | 0.44366530 |
110 | TAOK2 | 0.44129302 |
111 | MAP3K10 | 0.43537467 |
112 | PKN2 | 0.43526690 |
113 | FGFR3 | 0.43483953 |
114 | INSRR | 0.43224624 |
115 | CASK | 0.42829505 |
116 | SYK | 0.42784133 |
117 | PDK3 | 0.42752264 |
118 | PDK4 | 0.42752264 |
119 | PRKCZ | 0.42402826 |
120 | MAP3K6 | 0.42192598 |
121 | ARAF | 0.41667643 |
122 | LATS2 | 0.41549245 |
123 | CCNB1 | 0.41412923 |
124 | CSNK1G2 | 0.40678781 |
125 | IRAK3 | 0.40337475 |
126 | HCK | 0.39591424 |
127 | JAK1 | 0.38940356 |
128 | TTN | 0.37771977 |
129 | PTK6 | 0.36583940 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.87152189 |
2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.82571556 |
3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.44307013 |
4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.40890778 |
5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.40672205 |
6 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.27787651 |
7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.24307435 |
8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.22011594 |
9 | Morphine addiction_Homo sapiens_hsa05032 | 2.17601761 |
10 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.15860335 |
11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.11363086 |
12 | Insulin secretion_Homo sapiens_hsa04911 | 2.04778458 |
13 | Salivary secretion_Homo sapiens_hsa04970 | 1.99083124 |
14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.84250738 |
15 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.84208349 |
16 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.82577087 |
17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.71152753 |
18 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.63021273 |
19 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.61616334 |
20 | Renin secretion_Homo sapiens_hsa04924 | 1.60132044 |
21 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.58770448 |
22 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.49947505 |
23 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.47801857 |
24 | Cocaine addiction_Homo sapiens_hsa05030 | 1.47470585 |
25 | Taste transduction_Homo sapiens_hsa04742 | 1.45898394 |
26 | Long-term depression_Homo sapiens_hsa04730 | 1.41528626 |
27 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.39777847 |
28 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.37320284 |
29 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.33678773 |
30 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.32838630 |
31 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.32441026 |
32 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.32369349 |
33 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.31620801 |
34 | * Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.29911662 |
35 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.28093362 |
36 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.26046945 |
37 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.21641718 |
38 | Glioma_Homo sapiens_hsa05214 | 1.21139500 |
39 | Gap junction_Homo sapiens_hsa04540 | 1.18897602 |
40 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.18541506 |
41 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.17297769 |
42 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.16460862 |
43 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.12767020 |
44 | Prion diseases_Homo sapiens_hsa05020 | 1.11339931 |
45 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.08377652 |
46 | Other glycan degradation_Homo sapiens_hsa00511 | 1.06886281 |
47 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.03117777 |
48 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.02997574 |
49 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.02120860 |
50 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.00549643 |
51 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.92181141 |
52 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.90107424 |
53 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.88697681 |
54 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.88457453 |
55 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.87969801 |
56 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.87453224 |
57 | Melanogenesis_Homo sapiens_hsa04916 | 0.86384384 |
58 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.86363387 |
59 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.85113572 |
60 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.84817823 |
61 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.83776083 |
62 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.82070604 |
63 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.80233985 |
64 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.78816498 |
65 | Axon guidance_Homo sapiens_hsa04360 | 0.78495226 |
66 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.75876901 |
67 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.75835580 |
68 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.75760512 |
69 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.72946217 |
70 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.69417178 |
71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.68413950 |
72 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.68348751 |
73 | Phototransduction_Homo sapiens_hsa04744 | 0.67022546 |
74 | * Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.66694662 |
75 | Bile secretion_Homo sapiens_hsa04976 | 0.66522916 |
76 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.64727406 |
77 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.63492625 |
78 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.63262008 |
79 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.62589938 |
80 | Endometrial cancer_Homo sapiens_hsa05213 | 0.62476609 |
81 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.61909868 |
82 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.61851751 |
83 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.61785308 |
84 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.61393172 |
85 | Thyroid cancer_Homo sapiens_hsa05216 | 0.60575673 |
86 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.60545077 |
87 | Circadian rhythm_Homo sapiens_hsa04710 | 0.60308799 |
88 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.60217299 |
89 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.59177391 |
90 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.58871412 |
91 | Colorectal cancer_Homo sapiens_hsa05210 | 0.58161449 |
92 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.58071026 |
93 | Endocytosis_Homo sapiens_hsa04144 | 0.57848408 |
94 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.56493362 |
95 | Tuberculosis_Homo sapiens_hsa05152 | 0.54257107 |
96 | Hepatitis B_Homo sapiens_hsa05161 | 0.53122506 |
97 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.52343562 |
98 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.51324539 |
99 | Amoebiasis_Homo sapiens_hsa05146 | 0.50920085 |
100 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.50473735 |
101 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49514810 |
102 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.49055194 |
103 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.48950424 |
104 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.47617430 |
105 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.46811556 |
106 | Leishmaniasis_Homo sapiens_hsa05140 | 0.46572525 |
107 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.46566183 |
108 | Insulin resistance_Homo sapiens_hsa04931 | 0.46250924 |
109 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.46203026 |
110 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.44445253 |
111 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.43078527 |
112 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.43010535 |
113 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.42822135 |
114 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41536150 |
115 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.40884855 |
116 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.40753253 |
117 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.40370847 |
118 | Platelet activation_Homo sapiens_hsa04611 | 0.37540096 |
119 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.36767821 |
120 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.36255101 |
121 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.34371076 |
122 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.33231453 |
123 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.32520731 |
124 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.32115206 |